🔴 Noveris Health Sciences is trading 7.41% down today as biotech weakness weighs on speculative healthcare shares

Noveris Health Sciences is trading at $0.12 (-7.41%) as biotechnology weakness and a broader risk-off session weigh on speculative healthcare shares.

• No new company-specific announcement was identified for September 1, 2026; the latest financing proposal remains an earlier C$500,000 convertible-debenture offering.
• The S&P 500, Nasdaq, and Dow were each down more than 0.5% in the provided market context.
• Recent selling follows declines of 10.00% on August 31 and 14.29% on August 28.